Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmaceuticals

Set Alert for Pharmaceuticals

New study backs efficacy of VetDC's canine lymphoma treatment

Pet cancer therapy specialist VetDC has said findings from a new study support the efficacy of its Tanovea-CA1 canine lymphoma treatment. 

Canine Cancer

EMA finds general decline in antibiotic use in EU, situation varying across countries

The European Medicines Agency (EMA) has found sales of antibiotics for animal use decreased by 13% in Europe between 2011 and 2015. 

Antimicrobial resistance Policy & Regulation

Aratana set to launch Entyce in US after delays

Pet health specialist Aratana Therapeutics is making its Entyce appetite stimulant for dogs available to US veterinarians. 

Aratana Therapeutics Pharmaceuticals

Zoetis to add cats to anesthetic's label

European authorities have given the go-ahead for the addition of cats to the label of Zoetis' SevoFlo.

Europe Feline

Animal antimicrobial use in Denmark falls again

Antimicrobial consumption by animals in Denmark in 2016 fell by a substantial 5%.

Europe Denmark

Antibiotic-free farms: An opportunity goes begging

Charlie Munger, a leading US investment guru and stock market expert once said: "Too little attention in economics [is given] to second-order and even higher-order effects. This defect is quite understandable because consequences have consequences and consequences of the consequences have consequences and so on."

Markets R&D

Aquaculture thought it had conquered its major problems but innovation is still a must

A panel of experts discussed the future of the fish health sector at the recent Aquaculture Innovation Summit in London. Animal Pharm editor Joseph Harvey attended to hear about an industry searching for next-generation answers to its unmet needs. 

Aquaculture R&D

Japan places limitations on the use of cefquinome

Japanese authorities have placed specific limitations on the use of cefquinome, a veterinary cephalosporin. 

Japan Policy & Regulation

Australia cracks down on illicit pet products

Australian border guards at airports have recently spent a week seeking out illicit pet medicines being imported from abroad and seized a number of suspicious packages. 

Policy & Regulation Pharmaceuticals

Assisi advances canine cancer pipeline with MUMS designation

US firm Assisi Research Laboratories has been granted a minor use minor species (MUMS) designation for a canine cancer treatment.

United States FDA

ViroVet adds Capricorn Venture Partners to series A

Belgian company ViroVet has added another €1.5 million ($1.76 million) to its working capital after completing the second closing of its series A financing round.

Vaccines Pharmaceuticals

MWI invests in osteoarthritis product development

US veterinary distributor MWI Animal Health is to pump cash into a start-up specializing in treatment of arthritis and rheumatoid conditions in companion animals.

Investments Osteoarthritis
See All
Advertisement
UsernamePublicRestriction

Register